National Survey of Neonatal Transfusion Practices. I: Red blood cell therapy

• Published in: Pediatrics (Evanston) 1993-03, Vol.91 (3), p.523-529
• Main Authors: LEVY, G. J, STRAUSS, R. G, WARKENTIN, P. I, PEPKOWITZ, S, MAUER, A. M, HINES, D, HUME, H, SCHLOZ, L, ALBANESE, M. A, BLAZINA, J, WERNER, A, SOTELO-AVILA, C, BARRASSO, C, BLANCHETTE, V
• Format: Article
• Language: English
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Babies; Biological and medical sciences; Blood Component Transfusion - standards; Blood Component Transfusion - utilization; Blood Donors; Blood Grouping and Crossmatching; Blood transfusions; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis; Health Knowledge, Attitudes, Practice; Hematocrit; Humans; Infant, Newborn - blood; Medical sciences; Pediatrics; Polls & surveys; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; United States
• ISSN: 0031-4005; 1098-4275
• DOI: 10.1542/peds.91.3.523

Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52% of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29% of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.